Poster: Paediatrics

Tacrolimus in pediatric liver recipients: population pharmacokinetic analysis during the first year post transplantation

Thursday 16 October, 2025

Objectives: Different tacrolimus pharmacokinetics (PK) models have been proposed to characterize the tacrolimus PK variability observed in pediatric liver transplantation….

Read more

Population Pharmacokinetics of Twice Daily Zidovudine (ZDV) in HIV-Infected Children and an Assessment of ZDV Exposure Following WHO Dosing Guidelines

Thursday 16 October, 2025

Objectives: Zidovudine (ZDV) is a component of HIV therapy for children but limited PK data are available on the widely…

Read more

Age-Corrected Creatinine is a Significant Covariate for Gentamicin Clearance in Neonates

Thursday 16 October, 2025

Objectives: Gentamicin is an antibiotic with a narrow therapeutic window, making therapeutic drug monitoring (TDM) vital. However, currently there is no…

Read more

Paediatric Pharmacokinetic methodologies: Evaluation and comparison

Thursday 16 October, 2025

Objectives: The “first dose in children” could be determined mainly by two approaches: A physiological approach (PBPK “Physiollogically based PharmacoKineticsmodel)…

Read more

Exposure to the biological anti-thymocyte globulin (ATG) in children receiving allogeneic-hematopoietic cell transplantation (HCT): towards individualized dosing to improve survival

Thursday 16 October, 2025

Objectives: To prevent graft versus host disease (GvHD) and rejection in hematopoietic cell transplantation (HCT), children receive anti-thymocyte globulin (ATG),…

Read more

Mapping in vitro and in vivo derived CYP3A ontogeny function: A critical comparison between various ontogeny models

Thursday 16 October, 2025

Objectives: The aims of this study are to:1) Deconvolute components of clearance based on known ontogenies and explore any age-dependence of…

Read more

Pharmacokinetic/Pharmacodynamic Simulations Of The vWF Targeting Nanobody® ALX-0081 In Pediatric Patients With TTP

Thursday 16 October, 2025

Objectives: Nanobodies® are therapeutic proteins based on the smallest functional fragments of heavy chain antibodies, naturally occurring in Camelidae. ALX-0081 is a bivalent Nanobody® drug…

Read more

Population pharmacokinetic study of gentamicin: a retrospective analysis in a large cohort of neonate patients

Thursday 16 October, 2025

Objectives: Gentamicin is one of the most commonly prescribed antibiotics for suspected or proven infection in newborns. Because of age-associated…

Read more

Population Pharmacokinetics of Intravenous Busulfan in Children: Revised Body Weight-Dependent NONMEM® Model to Optimize Dosing

Thursday 16 October, 2025

Objectives: Busulfan (Bu), a DNA-alkylating agent, is widely used for conditioning prior to bone marrow transplantation in both children and…

Read more

Population pharmacokinetics of Zidovudine and its metabolite in HIV-1 infected children: Evaluation doses recommended

Thursday 16 October, 2025

Objectives: To describe Zidovudine (ZDV) pharmacokinetics (PK) and its biotransformation to its metabolite (G-ZDV) in HIV-infected children, to identify factors…

Read more